(0.57%) 5 156.87 points
(0.12%) 38 722 points
(0.70%) 16 269 points
(0.77%) $78.71
(4.06%) $2.23
(1.07%) $2 333.40
(3.40%) $27.60
(-0.28%) $962.60
(-0.11%) $0.928
(-0.40%) $10.83
(-0.22%) $0.795
(-0.12%) $91.34
Live Chart Being Loaded With Signals
Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and manufacture of oral, controlled-release products and generic pharmaceuticals...
Stats | |
---|---|
今日成交量 | 232 529 |
平均成交量 | 937 968 |
市值 | 126.75M |
EPS | $0 ( 2024-02-14 ) |
下一个收益日期 | ( $0 ) 2024-06-29 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 6.23 |
ATR14 | $0.00100 (0.80%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-29 | Hakim Nasrat A | Buy | 49 534 368 | Common Stock |
2023-12-29 | Hakim Nasrat A | Buy | 0 | |
2023-12-29 | Hakim Nasrat A | Buy | 2 223 147 | Common Stock |
2023-11-22 | Whitnell Jeffrey A | Buy | 547 657 | Common Stock |
2023-11-22 | Caskey Davis S | Buy | 547 657 | Common Stock |
INSIDER POWER |
---|
100.00 |
Last 94 transactions |
Buy: 545 075 953 | Sell: 326 529 955 |
音量 相关性
Elite Pharmaceuticals, 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Elite Pharmaceuticals, 相关性 - 货币/商品
Elite Pharmaceuticals, 财务报表
Annual | 2023 |
营收: | $34.16B |
毛利润: | $16.59B (48.58 %) |
EPS: | $4.35 |
FY | 2023 |
营收: | $34.16B |
毛利润: | $16.59B (48.58 %) |
EPS: | $4.35 |
FY | 2022 |
营收: | $32.26M |
毛利润: | $14.80M (45.86 %) |
EPS: | $0.00880 |
FY | 2021 |
营收: | $25.38M |
毛利润: | $11.87M (46.76 %) |
EPS: | $0.00540 |
Financial Reports:
No articles found.
Elite Pharmaceuticals,
Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and manufacture of oral, controlled-release products and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Products and New Drug Applications for Branded Products. It owns, licenses, and contract manufactures various generic and oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tablets for the treatment of bariatrics under Adipex-P brand; Phendimetrazine Tartrate 35mg tablets for bariatrics under the Bontril brand; Naltrexone HCl 50mg tablets for the treatment of pains under the Revia brand; and Isradipine 2.5mg and 5mg capsules for cardiovascular diseases. The company also provides Oxycodone HCl immediate release 5mg, 10mg, 15mg, 20mg, and 30mg tablets for pains under Roxycodone brand; Trimipramine Maleate Immediate Release antidepressant capsules under the Surmontil brand; Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Immediate Release tablets for central nervous system diseases under the Adderall brand, as well as Dantrolene Sodium capsules for muscle relaxant under the Dantrium brand; SequestOX, an immediate release Oxycodone with Naltrexone; Loxapine Succinate capsules for treating antipsychotic under the brand Loxapine; Acetaminophen and Codeine Phosphate for the management of mild to moderate pain; and antibiotic products. In addition, it manufactures controlled-release products on a contract basis for third parties in the areas of pain, allergy, bariatric, and infection. Further, the company is developing a range of abuse deterrent opioid products. The company was incorporated in 1997 and is headquartered in Northvale, New Jersey.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。